Improved design of the annual influenza vaccine using epitope analysis

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

The viral constituents in an influenza vaccine are decided annually based on global surveillance data, phylogenetic or whole-sequence comparisons of hemagglutinin and neuraminidase (viral coat proteins). The virus strains in circulation are monitored and cross reactivity with vaccine components is predicted. An optimal match between vaccine components and circulating virus provides maximal efficacy, while a suboptimal match can have a significant effect on morbidity and mortality. The paper under evaluation offers an analytical tool that has the potential to increase the chances of designing an optimal formulation. The analysis is carried out on the 2003-2004 influenza season and is used to explain clinical observations.

LanguageEnglish
Pages157-161
Number of pages5
JournalExpert Review of Vaccines
Volume4
Issue number2
DOIs
Publication statusPublished - 1 Apr 2005

Fingerprint

Influenza Vaccines
Epitopes
Cross Circulation
Vaccines
Viral Structures
Hemagglutinins
Neuraminidase
Capsid Proteins
Human Influenza
Viruses
Morbidity
Mortality

Keywords

  • antigenic drift
  • epitope analysis
  • influenza vaccine
  • original antigenic sin
  • predicted immune responses
  • statistical mechanics
  • vaccine design

Cite this

@article{771fac201f944748abcf448c1dafed71,
title = "Improved design of the annual influenza vaccine using epitope analysis",
abstract = "The viral constituents in an influenza vaccine are decided annually based on global surveillance data, phylogenetic or whole-sequence comparisons of hemagglutinin and neuraminidase (viral coat proteins). The virus strains in circulation are monitored and cross reactivity with vaccine components is predicted. An optimal match between vaccine components and circulating virus provides maximal efficacy, while a suboptimal match can have a significant effect on morbidity and mortality. The paper under evaluation offers an analytical tool that has the potential to increase the chances of designing an optimal formulation. The analysis is carried out on the 2003-2004 influenza season and is used to explain clinical observations.",
keywords = "antigenic drift, epitope analysis, influenza vaccine, original antigenic sin, predicted immune responses, statistical mechanics, vaccine design",
author = "Ferro, {Valerie A.}",
year = "2005",
month = "4",
day = "1",
doi = "10.1586/14760584.4.2.157",
language = "English",
volume = "4",
pages = "157--161",
journal = "Expert Review of Vaccines",
issn = "1476-0584",
number = "2",

}

Improved design of the annual influenza vaccine using epitope analysis. / Ferro, Valerie A.

In: Expert Review of Vaccines, Vol. 4, No. 2, 01.04.2005, p. 157-161.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Improved design of the annual influenza vaccine using epitope analysis

AU - Ferro, Valerie A.

PY - 2005/4/1

Y1 - 2005/4/1

N2 - The viral constituents in an influenza vaccine are decided annually based on global surveillance data, phylogenetic or whole-sequence comparisons of hemagglutinin and neuraminidase (viral coat proteins). The virus strains in circulation are monitored and cross reactivity with vaccine components is predicted. An optimal match between vaccine components and circulating virus provides maximal efficacy, while a suboptimal match can have a significant effect on morbidity and mortality. The paper under evaluation offers an analytical tool that has the potential to increase the chances of designing an optimal formulation. The analysis is carried out on the 2003-2004 influenza season and is used to explain clinical observations.

AB - The viral constituents in an influenza vaccine are decided annually based on global surveillance data, phylogenetic or whole-sequence comparisons of hemagglutinin and neuraminidase (viral coat proteins). The virus strains in circulation are monitored and cross reactivity with vaccine components is predicted. An optimal match between vaccine components and circulating virus provides maximal efficacy, while a suboptimal match can have a significant effect on morbidity and mortality. The paper under evaluation offers an analytical tool that has the potential to increase the chances of designing an optimal formulation. The analysis is carried out on the 2003-2004 influenza season and is used to explain clinical observations.

KW - antigenic drift

KW - epitope analysis

KW - influenza vaccine

KW - original antigenic sin

KW - predicted immune responses

KW - statistical mechanics

KW - vaccine design

UR - http://www.scopus.com/inward/record.url?scp=17144417738&partnerID=8YFLogxK

U2 - 10.1586/14760584.4.2.157

DO - 10.1586/14760584.4.2.157

M3 - Review article

VL - 4

SP - 157

EP - 161

JO - Expert Review of Vaccines

T2 - Expert Review of Vaccines

JF - Expert Review of Vaccines

SN - 1476-0584

IS - 2

ER -